Developing physiologically relevant tissue models is crucial for predicting clinical drug efficacy. Utilizing CELLINK's advanced bioprinting platforms, researchers can easily fabricate complex, multi-cellular 3D microenvironments mimicking native human tumors; it helps with accurate assessment of drug penetration and toxicity compared to traditional 2D cultures, accelerating lead candidate selection.